Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 3/20 | 0.36 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.36 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 2/20 | 0.34 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | USP8 | P40818 | 1/20 | 0.30 |
| ▸ | USP7 | Q93009 | 1/20 | 0.30 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15895318 | 0.96 | PDK2 (0.34) | IMPDH2IMPDH1NCOA3ARNSD2 | |
| SCHEMBL15895408 | 0.96 | PDK2 (0.34) | IMPDH2IMPDH1NCOA3ARNSD2 | |
| SCHEMBL15895345 | 0.92 | NSD2 (0.32) | IMPDH2IMPDH1NCOA3ARNSD2 | |
| SCHEMBL2606511 | 0.91 | PDK2 (0.39) | ALKPGRPDK2 | |
| SCHEMBL15895347 | 0.91 | SLC22A12 (0.37) | IMPDH2IMPDH1NCOA3CA1CA2 | |
| SCHEMBL15895349 | 0.91 | ALK (0.33) | IMPDH2IMPDH1NCOA3ARNSD2 | |
| SCHEMBL15895262 | 0.91 | NCOA3 (0.31) | IMPDH2IMPDH1NCOA3 | |
| SCHEMBL15895401 | 0.89 | PDK2 (0.33) | IMPDH2IMPDH1NCOA3NSD2ALK | |
| SCHEMBL15895402 | 0.89 | PDK2 (0.33) | IMPDH2IMPDH1NCOA3NSD2ALK | |
| SCHEMBL15895807 | 0.89 | AR (0.33) | IMPDH2IMPDH1NCOA3AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10559756-B2 | Materials for electronic devices | MERCK PATENT GMBH (DE) | 2020-02-11 | — | — | US | disclosed |
| US-20190319194-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-10-17 | — | — | US | disclosed |
| US-20160254456-A1 | Materials for Electronic Devices | MERCK PATENT GMBH (DE) | 2016-09-01 | — | — | US | disclosed |
| WO-2014111269-A2 | MATERIALS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2014-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160254456-A1 | Materials for Electronic Devices | FHIT, TEC, EED | IMPDH2 2270/4885IMPDH1 2997/4885NCOA3 2848/4885 |
| US-10559756-B2 | Materials for electronic devices | TEC, EFNA1, BMI1 | IMPDH2 1985/4885IMPDH1 2015/4885NCOA3 3332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.